staurosporine has been researched along with carnitine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biselli, R; De Simone, C; Farrace, S; Fattorossi, A | 1 |
| Adachi, S; Babior, BM; Esser, V; Gottlieb, RA; Konyavko, M; McGarry, JD; Mutomba, MC; Yokoyama, CB; Yuan, H | 1 |
| Angelini, A; Calvani, M; Dalla Libera, L; Della Barbera, M; Dona, M; Gobbo, V; Mosconi, L; Peluso, G; Ravara, B; Sandri, M; Vescovo, G | 1 |
3 other study(ies) available for staurosporine and carnitine
| Article | Year |
|---|---|
Potentiation of human polymorphonuclear leukocyte activation by atrial natriuretic peptide. Inhibitory effect of carnitine congeners.
Topics: Atrial Natriuretic Factor; Carnitine; Cell Adhesion; Cell Membrane; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hydrogen Peroxide; L-Selectin; Leukotriene B4; Macrophage-1 Antigen; Myocardial Reperfusion Injury; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Palmitoylcarnitine; Protein Kinase C; Reactive Oxygen Species; Staurosporine | 1996 |
Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine.
Topics: Acylation; Apoptosis; Carnitine; Carnitine O-Palmitoyltransferase; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; fas Receptor; Fibroblasts; Humans; Jurkat Cells; Palmitoyl Coenzyme A; Palmitoylcarnitine; Staurosporine | 2000 |
L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Carnitine; Caspase 3; Caspase 9; Caspases; Cell Nucleus; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Glucose Transporter Type 4; Heart Failure; In Situ Nick-End Labeling; Liver Function Tests; Male; Monocrotaline; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Muscular Disorders, Atrophic; Myosin Heavy Chains; Protein Isoforms; Rats; Rats, Sprague-Dawley; Sphingolipids; Staurosporine; Tumor Necrosis Factor-alpha | 2002 |